Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.

Keyphrases

• Suprachiasmatic nucleus 100%
• Melatonin Receptor 2 100%
• Melatonin Receptors 100%
• 1 Receptor 100%
• Melatonin 22%
• Depressed Patients 22%
• Vasoactive Intestinal Peptide 22%
• Disease Course 11%
• Age of Onset 11%
• Circadian Rhythm 11%
• Paraventricular nucleus 11%
• Vasopressin 11%
• Neuropeptides 11%
• Supraoptic nucleus 11%
• Biological Clock 11%
• Pineal Hormone 11%
• Postmortem Study 11%
• Immunoreactivity 11%
• Immunoreactive Cells 11%
• 2 Receptor 11%
• Bipolar Disorder 11%
• Potential Therapy 11%
• Depression Onset 11%
• Circadian Disorders 11%
• Mood Disorders 11%
• Disease Duration 11%
• Major Depressive Disorder 11%
• Circadian System 11%
• Immunocytochemistry 11%

Neuroscience

• Suprachiasmatic Nucleus 100%
• Melatonin Receptor 100%
• Melatonin 2 Receptor 100%
• Melatonin 1 Receptor 100%
• Receptor 37%
• Melatonin 25%
• Melatonin Receptor Agonist 25%
• Vasoactive Intestinal Peptide 25%
• Circadian Rhythm 12%
• Neuropeptide 12%
• Supraoptic Nucleus 12%
• Agonist 12%
• Mood Disorder 12%
• Bipolar Disorder 12%
• Vasopressin 12%
• Biological Clock 12%
• Major Depressive Disorder 12%
• Immunocytochemistry 12%